Flavin Ventures' investment strategy is to convert the deal flow opportunities emerging from the excellent yet under exploited drug discovery technologies of Midwestern universities and leading medical and governmental institutions into successful, growth-oriented companies.

Flavin Ventures provides seed-stage venture capital and entrepreneurial expertise to life science companies expecting to cross the divide between proprietary research activities and commercial success. We also leverage the significant relationships that the managing directors have established with other venture capital groups, primarily located on the East and West coasts of the United States, into co-investment or follow-on investment activity in Flavin Ventures' portfolio companies.

One of Flavin Ventures’ most valuable assets is its management expertise in overcoming the scientific and financial obstacles that start-up life science companies inevitably encounter on their path toward success in the biotechnology arena.